16 September 2019
Farnesoid X nuclear receptor ligand obeticholic acid
For noncirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
Neuschwander-Tetri BA. et al. Lancet. 2015 Mar 14; 385(9972): 956–965.